Olshan Client TIG Advisors Joins Allergan Shareholders in Urging Board to Put Acquisitions to Shareholder Vote

Firm News

The Wall Street Journal’s coverage of Allergan’s ongoing defense against a hostile bid by Valeant Pharmaceuticals and Pershing Square reported that Olshan client, TIG Advisors, has delivered a letter to the Board of Directors of Allergan. TIG Advisors joined other Allergan shareholders in urging the Board to put any acquisitions by Allergan to a shareholder vote. The Wall Street Journal had reported earlier this week that Allergan was in advanced talks to acquire Salix Pharmaceuticals in a potentially all-cash deal. Steve Wolosky represents TIG Advisors in connection with its investment in Allergan.

Media Contact

Marketing Contact
Mizi Mehaj
Marketing & Administrative Manager
mmehaj@olshanlaw.com
212.451.2319


Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.